Trials / Completed
CompletedNCT01924962
Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries
A Randomized Comparison of Recanalisation With Implantation of Cypher Sirolimus Eluting Coronary Stents and Medical Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 205 (actual)
- Sponsor
- University Heart Center Freiburg - Bad Krozingen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a randomised comparison of recanalisation of chronic occluded coronary arteries with implantation of Sirolimus eluting stents and medical therapy. Myocardial function and scar-size are determinated by using magnetic resonance imaging. The study hypothesis is the superiority of medical therapy over revascularisation.
Detailed description
In the REVASC-study recovery of left ventricular function after recanalization of chronic total coronary occlusions (CTO) and implantation of sirolimus-eluting stents will be examined and compared to medical treatment. Extent of the scar, viable myocardium in the infarct zone and regional left ventricular function will be assessed by cardiac magnetic resonance. Patients with regional systolic left ventricular dysfunction of any degree in the supply territory of the CTO vessel will be randomized to either recanalization of the occluded coronary artery or to conservative therapy. It is of interest whether CTO patients will have an improvement in left ventricular function after late coronary reopening, regarding the high technical demands and costs of CTO recanalization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | revascularisation | revascularisation of chronic occluded coronary artery |
Timeline
- Start date
- 2008-05-28
- Primary completion
- 2016-08-14
- Completion
- 2017-06-16
- First posted
- 2013-08-19
- Last updated
- 2017-11-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01924962. Inclusion in this directory is not an endorsement.